These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 9152383

  • 1. Agonist-independent effect of an allosteric enhancer of the A1 adenosine receptor in CHO cells stably expressing the recombinant human A1 receptor.
    Kollias-Baker CA, Ruble J, Jacobson M, Harrison JK, Ozeck M, Shryock JC, Belardinelli L.
    J Pharmacol Exp Ther; 1997 May; 281(2):761-8. PubMed ID: 9152383
    [Abstract] [Full Text] [Related]

  • 2. Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells.
    Shryock JC, Ozeck MJ, Belardinelli L.
    Mol Pharmacol; 1998 May; 53(5):886-93. PubMed ID: 9584215
    [Abstract] [Full Text] [Related]

  • 3. Effects of long-term treatment with the allosteric enhancer, PD81,723, on Chinese hamster ovary cells expressing recombinant human A1 adenosine receptors.
    Bhattacharya S, Linden J.
    Mol Pharmacol; 1996 Jul; 50(1):104-11. PubMed ID: 8700102
    [Abstract] [Full Text] [Related]

  • 4. Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723.
    Musser B, Mudumbi RV, Liu J, Olson RD, Vestal RE.
    J Pharmacol Exp Ther; 1999 Feb; 288(2):446-54. PubMed ID: 9918544
    [Abstract] [Full Text] [Related]

  • 5. The allosteric enhancer, PD 81,723, stabilizes human A1 adenosine receptor coupling to G proteins.
    Bhattacharya S, Linden J.
    Biochim Biophys Acta; 1995 Feb 16; 1265(1):15-21. PubMed ID: 7857979
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivatives.
    Gao ZG, Kim SG, Soltysiak KA, Melman N, IJzerman AP, Jacobson KA.
    Mol Pharmacol; 2002 Jul 16; 62(1):81-9. PubMed ID: 12065758
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor.
    Kourounakis A, Visser C, de Groote M, IJzerman AP.
    Biochem Pharmacol; 2001 Jan 15; 61(2):137-44. PubMed ID: 11163328
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of the adenosine A(1) receptor allosteric enhancer PD 81,723 on agonist binding to brain and adipocyte membranes.
    Jarvis MF, Gessner G, Shapiro G, Merkel L, Myers M, Cox BF, Martin GE.
    Brain Res; 1999 Sep 04; 840(1-2):75-83. PubMed ID: 10517954
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.
    Bruns RF, Fergus JH.
    Mol Pharmacol; 1990 Dec 04; 38(6):939-49. PubMed ID: 2174510
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells.
    Kudlacek O, Just H, Korkhov VM, Vartian N, Klinger M, Pankevych H, Yang Q, Nanoff C, Freissmuth M, Boehm S.
    Neuropsychopharmacology; 2003 Jul 04; 28(7):1317-27. PubMed ID: 12784121
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.